Skip to main content
. Author manuscript; available in PMC: 2017 Aug 14.
Published in final edited form as: J Mol Biol. 2016 Feb 12;428(16):3221–3229. doi: 10.1016/j.jmb.2016.02.010

Fig. 4. Reversible alterations of the MUC2 O-glycans upon active inflamed ulcerative colitis (UC).

Fig. 4

Major MUC2 O-glycans in human sigmoid colon of control individuals and patients with inactive UC disease. Arrows show alterations in patients with active UC. The relative amounts of the glycosyltransferases used for the biosynthesis of the glycans in human control individuals are shown as dots. Results from Holmen-Larsson et al. [74] and van der Post et al. [64].